TY  - ADVS
AU  - Buyse,Marc E.
TI  - Biomarkers and surrogate endpoints in randomized clinical trials
T2  - Design and analysis of randomized clinical trials : design, analysis & theory,
PY  - 2016///
CY  - London
PB  - Henry Stewart Talks
KW  - Antineoplastic agents
KW  - Testing
KW  - Biochemical markers
KW  - Clinical trials
KW  - Statistical methods
KW  - Research
KW  - Design
KW  - Tumor markers
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - Biometry
KW  - methods
KW  - Neoplasms
KW  - drug therapy
KW  - Prognosis
KW  - Randomized Controlled Trials as Topic
KW  - statistics & numerical data
KW  - Research Design
N1  - Animated audio-visual presentation with synchronized narration; Title from title frames; Updated version of a talk first published in 2007; Contents: Definitions (prognostic biomarker, predictive biomarker, surrogate endpoint) -- Statistical validation of biomarkers -- Examples of surrogate endpoints in oncology; Access restricted to subscribers
UR  - https://hstalks.com/bs/554/
UR  - https://hstalks.com/bs/p/15/
ER  -